TCIM
TIAA CREF Investment Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $181M | Buy |
2,040,932
+555,842
| +37% | +$49.4M | 0.13% | 162 |
|
|
2018
Q4 | $126M | Buy |
1,485,090
+165,646
| +13% | +$14.1M | 0.1% | 195 |
|
|
2018
Q3 | $128M | Buy |
1,319,444
+255,291
| +24% | +$24.8M | 0.08% | 226 |
|
|
2018
Q2 | $100M | Sell |
1,064,153
-349,191
| -25% | -$32.9M | 0.07% | 270 |
|
|
2018
Q1 | $115M | Sell |
1,413,344
-323,342
| -19% | -$26.2M | 0.08% | 255 |
|
|
2017
Q4 | $155M | Sell |
1,736,686
-410,022
| -19% | -$36.6M | 0.1% | 206 |
|
|
2017
Q3 | $200M | Sell |
2,146,708
-104,303
| -5% | -$9.71M | 0.14% | 153 |
|
|
2017
Q2 | $204M | Buy |
2,251,011
+875,686
| +64% | +$79.5M | 0.14% | 157 |
|
|
2017
Q1 | $121M | Buy |
1,375,325
+151,663
| +12% | +$13.3M | 0.09% | 251 |
|
|
2016
Q4 | $101M | Sell |
1,223,662
-163,529
| -12% | -$13.5M | 0.08% | 268 |
|
|
2016
Q3 | $128K | Sell |
1,387,191
-8,625
| -0.6% | -$798 | 0.08% | 240 |
|
|
2016
Q2 | $109M | Sell |
1,395,816
-149,568
| -10% | -$11.6M | 0.08% | 249 |
|
|
2016
Q1 | $127M | Sell |
1,545,384
-48,385
| -3% | -$3.99M | 0.1% | 210 |
|
|
2015
Q4 | $167M | Buy |
1,593,769
+111,026
| +7% | +$11.6M | 0.13% | 173 |
|
|
2015
Q3 | $156M | Sell |
1,482,743
-542,067
| -27% | -$57.1M | 0.12% | 179 |
|
|
2015
Q2 | $277M | Sell |
2,024,810
-222,273
| -10% | -$30.4M | 0.2% | 101 |
|
|
2015
Q1 | $280M | Buy |
2,247,083
+145,634
| +7% | +$18.1M | 0.2% | 115 |
|
|
2014
Q4 | $190M | Buy |
2,101,449
+1,247,649
| +146% | +$113M | 0.13% | 174 |
|
|
2014
Q3 | $61.6M | Buy |
853,800
+176,792
| +26% | +$12.8M | 0.04% | 427 |
|
|
2014
Q2 | $42.1M | Buy |
677,008
+185,815
| +38% | +$11.6M | 0.03% | 529 |
|
|
2014
Q1 | $33.5M | Buy |
491,193
+185,728
| +61% | +$12.7M | 0.02% | 610 |
|
|
2013
Q4 | $21.5M | Sell |
305,465
-63,203
| -17% | -$4.44M | 0.02% | 759 |
|
|
2013
Q3 | $26.6M | Sell |
368,668
-190,288
| -34% | -$13.7M | 0.02% | 655 |
|
|
2013
Q2 | $31.2M | Buy |
+558,956
| New | +$31.2M | 0.03% | 581 |
|